Neuroendocrine Response and State Anxiety Due to Psychosocial Stress Decrease after a Training with Subject's Own (but Not Another) Virtual Body: An RCT Study.

agency anxiety body ownership immersive virtual reality training psychosocial stress salivary alpha-amylase

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
23 05 2022
Historique:
received: 06 04 2022
revised: 12 05 2022
accepted: 19 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

Previous research involving healthy participants has reported that seeing a moving virtual body from the first person perspective induces the illusion of ownership and agency over that virtual body. When a person is sitting and the virtual body runs, it is possible to measure physiological, behavioral and cognitive reactions that are comparable to those that occur during actual movement. Capitalizing on this evidence, we hypothesized that virtual training could also induce neuroendocrine effects that prompt a decreased psychosocial stress response, as occurs after physical training. While sitting, 26 healthy young adults watched a virtual avatar running for 30 min from the first person perspective (experimental group), while another 26 participants watched the virtual body from the third person perspective (control group). We found a decreased salivary alpha-amylase concentration (a biomarker for the stress response) after the virtual training among the experimental group only, as well as a decreased subjective feeling of state anxiety (but no difference in heart rate). We argue that the virtual illusion of a moving body from the first person perspective can initiate a cascade of events, from the perception of the visual illusion to physiological activation that triggers other biological effects, such as the neuroendocrine stress response.

Identifiants

pubmed: 35627877
pii: ijerph19106340
doi: 10.3390/ijerph19106340
pmc: PMC9140346
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Références

Conscious Cogn. 2013 Sep;22(3):779-87
pubmed: 23727712
Anxiety Stress Coping. 2018 Mar;31(2):135-145
pubmed: 29037088
Behav Brain Res. 2014 Mar 15;261:275-81
pubmed: 24412686
Conscious Cogn. 2018 Feb;58:186-192
pubmed: 29305042
Biol Psychol. 2019 Nov;148:107729
pubmed: 31369830
Front Hum Neurosci. 2021 May 31;15:674326
pubmed: 34135743
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12846-51
pubmed: 23858436
Sci Rep. 2016 Jul 01;6:28879
pubmed: 27364767
Psychoneuroendocrinology. 2014 May;43:41-51
pubmed: 24703169
Dialogues Clin Neurosci. 2015 Sep;17(3):327-35
pubmed: 26487813
Biol Psychol. 2012 Jan;89(1):99-106
pubmed: 22001447
Biol Psychol. 2015 Jul;109:111-9
pubmed: 25976524
Front Hum Neurosci. 2014 May 15;8:320
pubmed: 24860486
PLoS One. 2014 Aug 25;9(8):e105670
pubmed: 25153526
Front Hum Neurosci. 2013 Jul 31;7:438
pubmed: 23914172
PLoS One. 2015 Mar 16;10(3):e0117155
pubmed: 25775041
Neuropsychologia. 2010 Feb;48(3):703-12
pubmed: 19819247
Psychoneuroendocrinology. 2015 Jan;51:227-36
pubmed: 25462896
Sports Med. 2018 Nov;48(11):2607-2622
pubmed: 30159718
Sports Med Open. 2016 Dec;2(1):33
pubmed: 27747788
Appl Psychophysiol Biofeedback. 2012 Jun;37(2):103-7
pubmed: 22318453
PLoS One. 2010 May 12;5(5):e10564
pubmed: 20485681
Psychoneuroendocrinology. 2019 Aug;106:216-225
pubmed: 31003138
Front Psychol. 2018 Jun 11;9:917
pubmed: 29942270
Dev Psychobiol. 2017 Jan;59(1):91-98
pubmed: 27577885
Front Hum Neurosci. 2013 Mar 21;7:83
pubmed: 23519597
Health Psychol. 2006 Nov;25(6):723-39
pubmed: 17100501
Ann N Y Acad Sci. 2004 Dec;1032:258-63
pubmed: 15677423
Acta Psychol (Amst). 2018 Apr;185:219-228
pubmed: 29533775
Trials. 2019 Sep 11;20(1):559
pubmed: 31511036
Conscious Cogn. 2008 Mar;17(1):219-39
pubmed: 17482480
Curr Opin Behav Sci. 2019 Aug;28:58-65
pubmed: 32215283
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Physiol Behav. 2021 Oct 15;240:113549
pubmed: 34371023
Psychol Sci. 2021 May;32(5):655-667
pubmed: 33826456
Psychosom Med. 1996 Jul-Aug;58(4):374-82
pubmed: 8827800
Neuroimage. 2015 Oct 1;119:235-51
pubmed: 26123376
BMJ Open. 2020 Jul 5;10(7):e034849
pubmed: 32624469
J Vis Exp. 2011 Oct 19;(56):
pubmed: 22042290
Age Ageing. 2021 Jun 28;50(4):1261-1267
pubmed: 33480986
BMC Neurol. 2015 Nov 12;15:233
pubmed: 26563170
Sci Rep. 2015 Sep 10;5:13899
pubmed: 26354311
Psychophysiology. 1997 May;34(3):266-75
pubmed: 9175441
Sci Rep. 2015 Nov 25;5:17139
pubmed: 26602036
PLoS One. 2019 Jan 3;14(1):e0209899
pubmed: 30605454
Psychoneuroendocrinology. 2005 Feb;30(2):199-211
pubmed: 15471617
Psychoneuroendocrinology. 2011 Oct;36(9):1294-302
pubmed: 21470780
Psychol Bull. 2004 May;130(3):355-91
pubmed: 15122924
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17678-83
pubmed: 25422444
Biol Psychol. 2012 Dec;91(3):342-8
pubmed: 22954623
J Behav Ther Exp Psychiatry. 2012 Sep;43(3):967-74
pubmed: 22487103
Nat Rev Neurosci. 2008 Jan;9(1):58-65
pubmed: 18094706
Exerc Sport Sci Rev. 1996;24:267-87
pubmed: 8744253
Cognition. 2017 Sep;166:164-173
pubmed: 28577446
Monogr Oral Sci. 2014;24:99-108
pubmed: 24862598
J Behav Med. 2014 Dec;37(6):1118-33
pubmed: 24659155
Psychoneuroendocrinology. 2013 Mar;38(3):367-75
pubmed: 22819683
Neuropsychobiology. 1993;28(1-2):76-81
pubmed: 8255414
Neuroimage. 2020 Nov 15;222:117297
pubmed: 32828927
Nature. 1998 Feb 19;391(6669):756
pubmed: 9486643
Sci Rep. 2016 Aug 03;6:30628
pubmed: 27485049
Psychoneuroendocrinology. 2016 Jan;63:119-27
pubmed: 26441230

Auteurs

Dalila Burin (D)

Institute of Development, Aging and Cancer (IDAC), Tohoku University, 4-1 Seiryocho, Aobaku, Sendai 980-8575, Japan.
Smart Aging Research Center (SARC), Tohoku University, 4-1 Seiryocho, Aobaku, Sendai 980-8575, Japan.

Gabriele Cavanna (G)

Smart Aging Research Center (SARC), Tohoku University, 4-1 Seiryocho, Aobaku, Sendai 980-8575, Japan.
Graduate School of Science, Tohoku University, 6-3 Aramaki Aza-Aoba, Aobaku, Sendai 980-8578, Japan.

Daniela Rabellino (D)

Department of Psychiatry, Western University, 550 Wellington Rd., London, ON N6C 5J1, Canada.

Yuka Kotozaki (Y)

Division of Clinical Research and Epidemiology, Iwate Tohoku Medical Megabank Organization, Iwate Medical University, 1-1-1, Idaidori, Yahaba, Iwate, Morioka 028-3694, Japan.

Ryuta Kawashima (R)

Institute of Development, Aging and Cancer (IDAC), Tohoku University, 4-1 Seiryocho, Aobaku, Sendai 980-8575, Japan.
Smart Aging Research Center (SARC), Tohoku University, 4-1 Seiryocho, Aobaku, Sendai 980-8575, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH